Sensyne agrees settlement with LSE over IPO bonuses

London-listed clinical AI company Sensyne Health has agreed a £406,000 settlement with the London Stock Exchange for historical breaches of AIM rules regarding the payment of IPO bonuses in 2018. The original fine of £580,000 was reduced for early repayment and Sensyne, which is currently exploring options for a potential management buyout, said it had fully…

You must be a HM Subscriber to view this content.

Subscribe Now »